Genflow Biosciences enters AI gene therapy research deal#Genflow #Biosciences #enters #gene #therapy #research #deal
Tag: Biosciences
Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space
Solid Biosciences: A Strong Buy As An Emerging Biotech In The Gene Therapy Space #Solid #Biosciences…
Does Colossal Biosciences’ dire wolf creation justify its $10B+ valuation?
On Monday, the “de-extinction” startup Colossal Biosciences announced its most ambitious results to date: the dire…
Ventyx Biosciences chief scientific officer John Nuss sells $2,019 in shares
Ventyx Biosciences chief scientific officer John Nuss sells $2,019 in shares#Ventyx #Biosciences #chief #scientific #officer #John…
Ideaya Biosciences stock hits 52-week low at $16.95
Ideaya Biosciences stock hits 52-week low at $16.95#Ideaya #Biosciences #stock #hits #52week
Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript
Pulse Biosciences, Inc. (PLSE) Q4 2024 Earnings Call Transcript #Pulse #Biosciences #PLSE #Earnings #Call #Transcript
Junshi Biosciences Announces Toripalimab's Approval in Singapore
Junshi Biosciences Announces Toripalimab's Approval in Singapore#Junshi #Biosciences #Announces #Toripalimab039s #Approval #Singapore
Harmony Biosciences: A Compelling Risk-Reward Opportunity
Harmony Biosciences: A Compelling Risk-Reward Opportunity #Harmony #Biosciences #Compelling #RiskReward #Opportunity
Pacira BioSciences: Back On An Uptrend After Positive Developments
Pacira BioSciences: Back On An Uptrend After Positive Developments #Pacira #BioSciences #Uptrend #Positive #Developments
PCRX IMPORTANT DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 14 Deadline in Secu
PCRX IMPORTANT DEADLINE: ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Pacira BioSciences, Inc. Investors with Losses…
On a quest to revive the woolly mammoth, Colossal Biosciences has created a woolly mouse
Colossal Biosciences, known for its outlandish goal to resurrect the woolly mammoth by 2028, is claiming…
PCRX FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 14 Deadline in Securities Cl
PCRX FINAL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Pacira BioSciences, Inc. Investors with Losses in Excess…
Faruqi & Faruqi Reminds Pacira BioSciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 14, 2025 – PCRX
Faruqi & Faruqi Reminds Pacira BioSciences Investors of the Pending Class Action Lawsuit with a Lead…
Pacira BioSciences, Inc. (PCRX) Q4 2024 Earnings Call Transcript
Pacira BioSciences, Inc. (PCRX) Q4 2024 Earnings Call Transcript #Pacira #BioSciences #PCRX #Earnings #Call #Transcript
Harmony Biosciences Holdings, Inc. 2024 Q4 – Results – Earnings Call Presentation (NASDAQ:HRMY)
This article was written by Follow Seeking Alpha’s transcripts team is responsible for the development of…
FINAL CRBU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Caribou Biosciences, Inc. Investors to Join the Class Action Lawsuit
FINAL CRBU DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Caribou Biosciences, Inc. Investors to Join the…
CRBU DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Caribou Biosciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 24 Deadline in
CRBU DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Caribou Biosciences, Inc. Investors with…
CRBU DEADLINE MONDAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action – CRBU
CRBU DEADLINE MONDAY: ROSEN, NATIONAL TRIAL LAWYERS, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before…
Aura Biosciences senior VP sells $10,881 in stock to cover taxes
Aura Biosciences senior VP sells $10,881 in stock to cover taxes#Aura #Biosciences #senior #sells #stock #cover…
CRBU DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure Counsel Before Important February 24 Deadline in Securities Class Action – CRBU
CRBU DEADLINE NOTICE: ROSEN, A TOP RANKED LAW FIRM, Encourages Caribou Biosciences, Inc. Investors to Secure…
Neurocrine Biosciences chief scientific officer sells $336,238 in stock
Neurocrine Biosciences chief scientific officer sells $336,238 in stock#Neurocrine #Biosciences #chief #scientific #officer #sells #stock
Neurocrine Biosciences CFO sells shares worth $298,922
Neurocrine Biosciences CFO sells shares worth $298,922#Neurocrine #Biosciences #CFO #sells #shares #worth